The purpose of this study was to assess the effects of daily SSTR2a administration for up to 11 days on overall glycemia and glucagon responses, in a male rat model of insulin-treated T2D, with and without hypoglycemia. The gene discussed is GCG; the disease is Hypoglycemia.